Trump's acting attorney general moved to reclassify medical marijuana under federal law

Quartz Quartz

The DOJ order immediately shifts FDA-approved and state-licensed cannabis products to Schedule III, lowering barriers to research and easing tax burdens on cannabis companies

Read full article at Quartz →